摘要 |
The present application is directed to a method of inhibiting HDAC in the brain of a mammal. The method comprises administering to a mammal a HDAC inhibiting amount of a histone deacetylase inhibitor compound. The present application is further directed to a method of treating diseases of the central nervous system (CNS) comprising administering to a individual in need of treatment a therapeutically effective amount of an inhibitor of HDAC. In particular embodiments, the CNS disease is a neurodegenerative disease. In further embodiments, the neurogenerative disease is an inherited neurodegenerative disease, such as those inherited neurodegenerative diseases which are polyglutamine expansion diseases. In other embodiments, the disorder is cancer of the brain. The individual is a mammal, such as a primate or human. |
申请人 |
SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH;RICHON, VICTORIA, M.;MARKS, PAUL, A.;RIFKIND, RICHARD, A. |
发明人 |
RICHON, VICTORIA, M.;MARKS, PAUL, A.;RIFKIND, RICHARD, A. |